Dr Mateusz Wasylewski
Assistant professor in the Department of Bioethics.
PhD in Health Science, MSc of neurobiology, a graduate of the postgraduate course on organization, methodology and management of clinical trials.
A specialist in health technology assessment, systematic reviews of biomedical literature and systemic solutions in international health care. As a PhD student at the Faculty of Health Sciences of the Jagiellonian University Medical College, he explored issues related to research waste and the social value of early phase clinical trials in pediatrics.
As a researcher, he is mainly interested in questions of ethical and scientific validity of clinical, as well as preclinical research in biomedical sciences.
Member of the Commission for Ethics of Scientific Research of the Jagiellonian University – Collegium Medicum (1.09.2024- 31.08.2028).
Publications:
- Krawczyk, T., Piasecki, J., Wasylewski, M., Waligora, M. (2024). Ethics of research engagement with Deaf people. A qualitative evidence synthesis. The Journal of Deaf Studies and Deaf Education, enae024, https://doi.org/10.1093/jdsade/enae024
- Nilsonne G, Wieschowski S, DeVito NJ, et al. Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed. medRxiv doi: 10.1101/2024.02.04.24301363
- Meeuwis SH, Kłosowska J, Bajcar EA, Wasylewski MT, Badzińska J, Rubanets D, Di Nardo M, Mazzoni G, Bąbel P. Placebo Hypoalgesia and Nocebo Hyperalgesia Induced by Observational Learning May Be Difficult to Disentangle in a Laboratory Setting. J Pain 25(3): 805-818.
doi: 10.1016/j.jpain.2023.10.011 - Meeuwis, SH Wasylewski MT, Bajcar EA, Bieniek H, Adamczyk WM, Honcharova S, Di Nardo M, Mazzoni G, Bąbel P. Learning pain from others: a systematic review and meta-analysis of studies on placebo hypoalgesia and nocebo hyperalgesia induced by observational learning. PAIN 164(11): 2383-2396; doi: 10.1097/j.pain.0000000000002943
- Strzebonska K, Blukacz M, Wasylewski MT, Polak M, Gyawali B, Waligora M. Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis. BMC Med. 2022; 20:219. doi: 10.1186/s12916-022-02420-2
- Strzebonska K, Wasylewski MT, Zaborowska L, Polak M, Slugocka E, Stras J, Blukacz M, Gyawali B, Waligora M. Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis. Target Oncol. 2021; 16(4):415-424. doi:10.1007/s11523-021-00822-5
- Wasylewski MT, Strzebonska K, Koperny M, Polak M, Kimmelman J, Waligora M (2020), Clinical development success rates and social value of pediatric Phase 1 trials in oncology, PLoS ONE 15(6): e0234911. doi: 10.1371/journal.pone.0234911
- Strzebonska K, Wasylewski MT, Zaborowska L, Riedel N, Wieschowski S, Strech D, Waligora M (2020) Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis. BMJ Open 10(1):e034666. doi: 10.1136/bmjopen-2019-034666
- Waligora M, Bala MM, Koperny M, Wasylewski MT, Strzebonska K, Jaeschke RR, Wozniak A, Piasecki J, Sliwka A, Mitus JW, Polak M, Nowis D, Fergusson D, Kimmelman J (2018) Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis. PLoS Med. 15(2): e1002505. doi: 10.1371/journal.pmed.1002505
- Waligora M, Strzebonska K, Wasylewski MT (2018) Neither the Harm Principle nor the Best Interest Standard Should Be Applied to Pediatric Research. Am J Bioeth. 18(8):72 74. doi: 10.1080/15265161.2018.1485762
- Zhang Y, Morgan RL, Alonso-Coello P, Wiercioch W, Bała MM, Jaeschke RR, Styczeń K, Pardo-Hernandez H, Selva A, Ara Begum H, Morgano GP, Waligóra M, Agarwal A, Ventresca M, Strzebońska K, Wasylewski MT, Blanco-Silvente L, Kerth JL, Wang M, Zhang Y, Narsingam S, Fei Y, Guyatt G, Schünemann HJ (2018) A systematic review of how patients value COPD outcomes. Eur Respir J. 52(1). pii: 1800222. doi: 10.1183/13993003.00222-2018
- Wasylewski M (2017) Marnotrawstwo badawcze i postęp w medycynie. Filozofia w praktyce, Tom 3, art. 5
